Dynavax Technologies
DVAX
#5493
Rank
ยฃ0.96 B
Marketcap
ยฃ8.21
Share price
-0.09%
Change (1 day)
-19.11%
Change (1 year)

Dynavax Technologies (DVAX) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ0.21 Billion

According to Dynavax Technologies 's latest financial reports the company's total debt is ยฃ0.21 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Dynavax Technologies - Total debt on balance sheet (from 2009 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ0.20 B0.53%
2023-12-31ยฃ0.20 B-5.44%
2022-12-31ยฃ0.21 B11.85%
2021-12-31ยฃ0.19 B19.31%
2020-12-31ยฃ0.15 B-3.17%
2019-12-31ยฃ0.16 B107.71%
2018-12-31ยฃ79.46 M
2014-12-31ยฃ6.13 M
2012-12-31N/A-100%
2011-12-31ยฃ8.24 M7.98%
2010-12-31ยฃ7.63 M-0.25%
2009-12-31ยฃ7.65 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Agenus
AGEN
ยฃ34.28 M-83.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
ยฃ4.93 B 2,212.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
ยฃ30.99 B 14,415.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ18.68 B 8,650.49%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
ยฃ24.44 B 11,348.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
GlaxoSmithKline
GSK
ยฃ17.87 B 8,271.93%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
ยฃ45.57 B 21,248.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.78 B 5,890.02%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Amgen
AMGN
ยฃ40.88 B 19,051.72%๐Ÿ‡บ๐Ÿ‡ธ USA